MiR27a, which is up‐regulated by TNF‐α through the P38 pathway, blocks disc degeneration by targeting FSTL1 and can inhibit disc degeneration when expressed at high levels, thus providing a new potential therapeutic target for future treatment. Here, FSTL1 is linked to intervertebral disk degenerative disorder.